期刊文献+

25例肝癌中p16基因状态的研究 被引量:6

The status of p16 gene in primary hepatocellular carcinoma from a Chinese population
下载PDF
导出
摘要 目的:研究原发性肝细胞性肝癌中p16基因的状态。方法:采用多重PCR分析法、SSCP分析法及以PCR为基础的甲基化分析法分别对四川地区人群25例原发性肝细胞性肝癌标本及其相应的癌旁组织中p16基因的缺失、突变及甲基化情况进行了检测。结果:25例肿瘤标本中,发现3例p16基因缺失,其中2例纯合子缺失,1例半合子缺失,未发现1例突变,在未发现基因缺失的22例肿瘤标本中发现6例有p16基因高甲基化存在。全部相应的癌旁组织中均未发现有p16基因缺失、突变或甲基化存在。结论:p16基因的异常改变在原发性肝癌的发生与发展中可能起重要作用,其改变以甲基化为主。 Objective: To investigate the status of p16 gene in primary hepatocellular carcinoma (HCC). Methods: A total of 25 HCC samples with correspondant tumor-adjacent specimens were screened for p16 gene deletions, mutations and hypermethylations, by using multiplex polymerase chain reaction (PCR), single strand conformational polymorphism(SSCP) and PCR based methylation analysis, respectively. Results: Among 25 HCC samples, 2 homozygous and 1 hemizygous deletions and 6 hypermethylations were detected and no mutations were idendtified. However, no deletions, mutations or hypermethylations were found in all the tumor-adjacent tissues. Conclusion: The abnormal alterations of p16 gene may play an important role in the carcen genesis of primary hepatocellular carcinoma.
出处 《癌症》 SCIE CAS CSCD 北大核心 2000年第1期45-47,共3页 Chinese Journal of Cancer
关键词 P16基因 甲基化 肝肿瘤 基因突变 Primary hepatocellular carcinoma p16 gene Deletion Mutaion Hypermethylation.
  • 相关文献

二级参考文献63

共引文献189

同被引文献35

  • 1黄建钊,沈文律,李波,罗义刚,廖少希,张文,程娘.Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma[J].Chinese Medical Journal,2000(10):25-29. 被引量:6
  • 2[2]Uchida F, Kinoshiya F, Saita H, et al. CDKN2 (MTA1/p16INK4A)gene alterations in hematological malignancies[J]. Leak-Lymphoma, 1997,24(5): 449-461.
  • 3[3]Luca M, xie S, Gutran M, et al. Abnormalities in the CDKN2(p16 INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis[J]. Ontogeny, 1995, 11: 1399-1402.
  • 4[4]Heman JG, Merol A, Mao L, et al. Inactivation of the CDKN2/pl6/MTSI gene is frequently associated with aberrant DNA ethylating in all common human cancers[J]. Cancer Res, 1995,55: 4525-4530.
  • 5[5]Okamoto A, Demetrick DJ, Spillart EA, et al. Mutations and altered expression of p16 (INK4) in human cancer [J]. Prenatal Aced Sick USA, 1994, 19: 11045-11049.
  • 6[8]CHEN WM, ZHU JZ, LIU LZ, et al. methylamine of p16 gene in hematological malignancies [J]. Chin Med, 1998, 111:1028-1030.
  • 7[2]Uchida F,kinoshiya F,Saita H,et al.CDKN2(MTA1/p16INK4A)gene alterations in hematological malignancies[J].Leak-Lym phoma,1997,24(5-6):449-461
  • 8[3]Luca M,Xie S,Gutran M,et al.Abnormalities in the CDKN2(p16INK4/MTS-1) gene in human melanoma cells:relevance to tumor growth and metastasis.Ontogeny,1995,11:1399-1402
  • 9[4]Heman JG,Merlo A,Mao l,et al.Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA ethylating in all common human cancers.Cancer Res,1995,55:4525-4530
  • 10[5]Okamoto A,Demetrick DJ,Spillart EA,et al.Mutations and altered expression of p16 (INK4) in human cancer[J].Prenatal Aced Sick USA,1994,19:11045-11049

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部